Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹246.44
10.86 (4.61%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹2.01K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
49.6
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹87.15+182.8%
52W High₹248-0.6%
Current Price
₹246.44
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹197.15
Upper Circuit₹295.73
Reference Price
₹246.44
Investment Checklist
3-day momentum: +14.5% — strong upward pressure
Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Volume divergence: Bearish (price up, volume down)
RSI at 84.7 — overbought, pullback risk
Composite score 44.1 (BUY) with 81.6% confidence
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
82%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
EMA20
202.7
EMA50
176.54
EMA200
136.51
Price Action
MIXED
NEUTRAL
Higher Highs5
Higher Lows7
Lower Highs4
Lower Lows2
Support & Resistance Levels
Resistance (Above)
No recent resistance detected
Support (Below)
₹173.25
₹169.90
₹156.80
₹151.67
₹149.70
Volume Analysis
TrendSTABLE
Change-7.90%
Unusual VolumeNo
Divergence Detected
Bearish (price up, volume down)
Stop Loss Levels
Fixed Risk
1% Risk₹243.98
3% Risk₹239.05
5% Risk₹234.12
7% Risk (Custom)
₹229.19Technical Levels
1x ATR (Volatility)₹235.14
2x ATR (Swing)₹223.84
3x ATR (Trend)₹212.54
Immediate Support₹173.25
Moving Averages
EMA 9 (Short-term)₹221.37
EMA 20 (Medium-term)₹202.70
EMA 50 (Trend)₹176.54
EMA 200 (Long-term)₹136.51
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹128.8 Cr | ₹507.9 Cr | ₹152.6 Cr | ₹150.9 Cr |
| Net Profit | ₹-5.5 Cr | ₹249.1 Cr | ₹8 Cr | ₹9.5 Cr |
| EPS | ₹-0.82 | — | ₹1.00 | ₹1.17 |
| Operating Profit | ₹9.3 Cr | ₹281.8 Cr | ₹19.3 Cr | ₹25.9 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Ind-Swift Laboratories Limited | ₹246.44 | +4.61% | 49.6 | ₹2.01K Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 24 Sept 2024 | Annual General Meeting | AGM |
| 22 Sept 2023 | Annual General Meeting | AGM |
| 22 Sept 2022 | Annual General Meeting | AGM |
| 23 Sept 2021 | Annual General Meeting | AGM |
| 23 Sept 2020 | Annual General Meeting | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for INDSWFTLAB
View All
positive
LiveMint - Markets 15d ago
Rajesh Palviya of Axis Sec suggests JSW Infrastructure, Ind-Swift Laboratories, Welspun Living shares to buy next week
The Indian stock market will remain closed on June 26 for the Muharram holiday. Benchmark indices extended their winning streak ahead of the holiday, with Nifty 50 closing at 24,056 and Sensex at 77,100.47, boosted by easing crude oil prices and supportive measures for the rupee.
ABSLNN50ETAONETMMQ50AONETOTALAXISBPSETFBNKETFAXISCONSUMAXISESGGILT10BETAGILT5BETAGILT5YBEESGROWWNXT50GSEC10IETFGSEC10YEARGSEC5IETFHDFCNEXT50HDFCNIF100HEALTHAXISINDSWFTLABIOCITAXISJSWHLJSWINFRAJUNIORBEESLICNFNHGPLICNMID100LOWVOLLOWVOL1LOWVOLIETFLTGILTBEESLTGILTCASEMIDSMALLMOCAPITALMONEXT50MONIFTY100NEXT30ADDNEXT50NEXT50ADDNEXT50BETANEXT50ETFNEXT50IETFNIF100BEESNIF100IETFNIFTY100EWNIFTYAXISOILOILIETFSENSEXAXISSETFNN50SMALLCAPSML100CASESNXT30BEESSNXT50BETATOP100CASEWELCORPWELENTWELSPUNLIVCapital GoodsConstruction
NEWS
neutral
Business Standard - Markets 43d ago
Coffee Day Enterprises Ltd leads gainers in 'B' group
Tribhovandas Bhimji Zaveri Ltd, Ind-Swift Laboratories Ltd, Shivalik Rasayan Ltd and Network People Services Technologies Ltd are among the other gainers in the BSE's 'B' group today, 29 May 2026.
BSECOFFEEDAYINDSWFTLABNPSTSHIVALIKTBZTVTODAYChemicalsConsumer Durables
NEWS
positive
Google News - Investing.com India 86d ago
Ind-Swift Labs delivers 59% return after InvestingPro fair value alert By Investing.com - Investing.com India
Ind-Swift Labs delivers 59% return after InvestingPro fair value alert By Investing.comInvesting.com India
INDSWFTLABVALUEFinancial ServicesHealthcare